🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsPublic SquareWeekly check-in thread — need advice Page 3

Weekly check-in thread — need advice

greg_boulder Fri, Apr 5, 2024 at 2:30 AM 52 replies 2,715 viewsPage 3 of 11
VendorMark
Senior Member
3,456
14,567
Jan 2024
Texas
Online
Apr 6, 2024 at 11:05 PM#11
pat_auckland said:
Bayesian meta-analysis perspective on the trial evidence: traditional frequentist meta-analyses report point estimates and confidence intervals.

Correct, and worth adding that it is reversible. Nothing being described here is a one-way door, which changes how cautious it is reasonable to be.

Last edited: Apr 7, 2024 at 1:05 AM
22 22DebRD_ATL, KristenIndy, MarkLI_maint and 19 others
Reply Quote Save Share Report
pete_nash
Member
312
1,345
Aug 2024
Nashville, TN
Apr 8, 2024 at 9:21 AM#12
nick_SD_fit said:
Propensity score matching studies and the trial evidence: when RCTs aren't available for a specific question, propensity score-matched observational…

Genuinely useful, thank you. I had the facts and not the framework. Printing the relevant bit and taking it with me.

Last edited: Apr 8, 2024 at 3:21 PM
21 21Dr.Martinez, mike_mod, SarahChen_PharmD and 18 others
Reply Quote Save Share Report
Dr.PeteFamMed
Senior Member
2,012
9,234
Jan 2024
Minneapolis, MN
Apr 9, 2024 at 7:38 PM#13
pat_auckland said:
Bayesian meta-analysis perspective on the trial evidence: traditional frequentist meta-analyses report point estimates and confidence intervals.

This is where I part company with the consensus forming above. The objection nobody has made: this only works if the measurement is doing what we assume it is doing, and that assumption has not been tested here.

20 20LindaRN_retired, tommy_boulder, hyun_seoul and 17 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
TrialTracker_MD
Senior Member
2,345
15,678
Jan 2024
Maryland
Apr 11, 2024 at 5:55 AM#14

Adding the numbers, since they settle part of this. Worth stating the units and the reference range whenever you post a number here. A large fraction of the apparent disagreement in these threads is two people using different units and both being right.

That is the short version; the long version is somebody else's post.

19 19Dr.PulmRoch, maya_sedona, stefan_berlin and 16 others
Reply Quote Save Share Report
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
Apr 12, 2024 at 4:13 PM#15

Moderator note: a couple of off-topic posts removed. No action needed from anybody.

18 18PurityPaulOR, MaxMetOK, MounjBrad and 15 others
Reply Quote Save Share Report

Similar Threads

SELECT trial 4-year follow-up data released — sustained MACE reduction16 replies
GLP-1 receptor agonists and thyroid C-cell concerns — evidence review19 replies
Is there a ceiling effect for GLP-1-mediated weight loss?20 replies
Comparative pharmacokinetics: semaglutide vs tirzepatide vs retatrutide6 replies
My 18-month semaglutide journey — comprehensive data log20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register